$1.91 Billion is the total value of NEA Management Company, LLC's 50 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 27.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RARX | RA PHARMACEUTICALS INC | $294,724,000 | +2.3% | 6,138,797 | 0.0% | 15.40% | +13.0% | |
| OYST | OYSTER POINT PHARMA INC | $207,385,000 | +43.2% | 5,925,287 | 0.0% | 10.84% | +58.2% | |
| SPT | SPROUT SOCIAL INC | $144,375,000 | -0.6% | 9,046,080 | 0.0% | 7.54% | +9.9% | |
| ALLK | ALLAKOS INC | $100,912,000 | -53.3% | 2,268,188 | 0.0% | 5.27% | -48.4% | |
| NET | CLOUDFLARE INC | $95,314,000 | +33.8% | 4,059,376 | 0.0% | 4.98% | +47.8% | |
| ARDX | ARDELYX INC | $91,728,000 | -24.2% | 16,135,047 | 0.0% | 4.79% | -16.3% | |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $88,666,000 | -30.4% | 2,090,678 | 0.0% | 4.63% | -23.1% | |
| BDTX | New | BLACK DIAMOND THERAPEUTICS INC | $86,074,000 | – | 3,449,845 | +100.0% | 4.50% | – |
| AUPH | AURINIA PHARMACEUTICALS INC | $75,056,000 | -28.4% | 5,172,683 | 0.0% | 3.92% | -20.9% | |
| RYTM | RHYTHM PHARMACEUTICALS INC | $74,765,000 | -33.7% | 4,912,306 | 0.0% | 3.91% | -26.8% | |
| MRSN | MERSANA THERAPEUTICS INC | $69,748,000 | +1.7% | 11,963,649 | 0.0% | 3.64% | +12.4% | |
| EPZM | EPIZYME INC | $67,896,000 | -37.0% | 4,377,518 | 0.0% | 3.55% | -30.3% | |
| IMRA | New | IMARA INC | $64,395,000 | – | 4,017,170 | +100.0% | 3.36% | – |
| MIRM | MIRUM PHARMACEUTICALS INC | $58,629,000 | -42.9% | 4,187,801 | 0.0% | 3.06% | -36.9% | |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCadr | $46,465,000 | +144.6% | 17,082,611 | +7.9% | 2.43% | +170.4% |
| GRTX | GALERA THERAPEUTICS INC | $41,448,000 | -27.8% | 4,362,986 | 0.0% | 2.17% | -20.2% | |
| CSPR | New | CASPER SLEEP INC | $26,710,000 | – | 6,226,040 | +100.0% | 1.40% | – |
| Buy | TRILLIUM THERAPEUTICS INC | $23,175,000 | +971.4% | 5,736,363 | +173.2% | 1.21% | +1087.3% | |
| PHAS | PHASEBIO PHARMACEUTICALS INC | $21,991,000 | -45.8% | 6,643,704 | 0.0% | 1.15% | -40.2% | |
| GLYC | GLYCOMIMETICS INC | $20,723,000 | -56.9% | 9,089,041 | 0.0% | 1.08% | -52.4% | |
| SENS | Sell | SENSEONICS HOLDINGS INC | $18,750,000 | -34.0% | 29,761,683 | -3.6% | 0.98% | -27.1% |
| TRVI | TREVI THERAPEUTICS INC | $14,612,000 | -12.3% | 4,441,360 | 0.0% | 0.76% | -3.2% | |
| MEIP | MEI PHARMA INC | $13,738,000 | -35.1% | 8,533,072 | 0.0% | 0.72% | -28.3% | |
| CSBR | Buy | CHAMPIONS ONCOLOGY INC | $12,682,000 | -2.6% | 1,713,720 | +9.7% | 0.66% | +7.6% |
| GNCA | New | GENOCEA BIOSCIENCES INC | $12,428,000 | – | 7,225,676 | +100.0% | 0.65% | – |
| LQDA | LIQUIDIA TECHNOLOGIES INC | $11,709,000 | +10.0% | 2,486,062 | 0.0% | 0.61% | +21.7% | |
| XENE | XENON PHARMACEUTICALS INC | $11,250,000 | -13.5% | 992,107 | 0.0% | 0.59% | -4.4% | |
| OBSV | OBSEVA SA | $11,054,000 | -36.9% | 4,586,563 | 0.0% | 0.58% | -30.3% | |
| AFMD | AFFIMED NV | $9,680,000 | -42.3% | 6,126,488 | 0.0% | 0.51% | -36.3% | |
| MRKR | MARKER THERAPEUTICS INC | $9,500,000 | -34.0% | 5,000,000 | 0.0% | 0.50% | -27.2% | |
| MLND | MILLENDO THERAPEUTICS INC | $9,329,000 | -21.7% | 1,766,779 | 0.0% | 0.49% | -13.5% | |
| AVEO | New | AVEO PHARMACEUTICALS INC | $9,138,000 | – | 2,524,387 | +100.0% | 0.48% | – |
| SBBP | STRONGBRIDGE BIOPHARMA PLC | $7,827,000 | -9.7% | 4,141,308 | 0.0% | 0.41% | -0.2% | |
| SYBX | SYNLOGIC INC | $7,275,000 | -33.3% | 4,229,410 | 0.0% | 0.38% | -26.4% | |
| BE | BLOOM ENERGY CORP | $6,973,000 | -30.0% | 1,333,333 | 0.0% | 0.36% | -22.7% | |
| CTIC | Buy | CTI BIOPHARMA CORP | $6,569,000 | +12.8% | 7,140,450 | +90.4% | 0.34% | +24.7% |
| SURF | SURFACE ONCOLOGY INC | $6,199,000 | -0.5% | 3,315,149 | 0.0% | 0.32% | +9.8% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $5,059,000 | -27.1% | 3,243,150 | 0.0% | 0.26% | -19.5% | |
| VRNA | VERONA PHARMA PLCads | $5,025,000 | -28.3% | 1,219,674 | 0.0% | 0.26% | -20.8% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $4,646,000 | -53.0% | 2,382,286 | 0.0% | 0.24% | -48.0% | |
| LUMO | New | LUMOS PHARMA INC | $4,477,000 | – | 526,663 | +100.0% | 0.23% | – |
| DZSI | DASAN ZHONE SOLUTIONS INC | $4,007,000 | -52.7% | 956,255 | 0.0% | 0.21% | -47.9% | |
| ERYP | ERYTECH PHARMA SAadr | $3,338,000 | -27.5% | 625,000 | 0.0% | 0.17% | -20.2% | |
| XFOR | X4 PHARMACEUTICALS INC | $3,333,000 | -6.6% | 333,333 | 0.0% | 0.17% | +3.0% | |
| TRVN | TREVENA INC | $2,161,000 | -32.6% | 3,811,691 | 0.0% | 0.11% | -25.7% | |
| RGLS | REGULUS THERAPEUTICS INC | $946,000 | -48.2% | 2,052,455 | 0.0% | 0.05% | -43.0% | |
| AKTX | AKARI THERAPEUTICS PLCadr | $656,000 | -17.1% | 452,167 | 0.0% | 0.03% | -8.1% | |
| TCON | New | TRACON PHARMACEUTICALS INC | $589,000 | – | 346,718 | +100.0% | 0.03% | – |
| SNSS | SUNESIS PHARMACEUTICALS INC | $539,000 | +23.1% | 1,298,274 | 0.0% | 0.03% | +33.3% | |
| ELGXQ | New | ENDOLOGIX INC | $172,000 | – | 249,022 | +100.0% | 0.01% | – |
| ELGX | Exit | ENDOLOGIX INC | $0 | – | -249,021 | -100.0% | -0.02% | – |
| TCON | Exit | TRACON PHARMACEUTICALS INC | $0 | – | -346,718 | -100.0% | -0.04% | – |
| GNCA | Exit | GENOCEA BIOSCIENCES INC | $0 | – | -7,225,676 | -100.0% | -0.71% | – |
| AVEO | Exit | AVEO PHARMACEUTICALS INC | $0 | – | -25,243,865 | -100.0% | -0.74% | – |
| DERM | Exit | DERMIRA INC | $0 | – | -3,506,649 | -100.0% | -2.51% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-06
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GLYCOMIMETICS INC | 39 | Q3 2023 | 7.6% |
| AURINIA PHARMACEUTICALS INC | 37 | Q3 2023 | 5.0% |
| CHAMPIONS ONCOLOGY INC | 33 | Q3 2023 | 1.2% |
| LEXICON PHARMACEUTICALS INC | 32 | Q3 2023 | 2.0% |
| ADAPTIMMUNE THERAPEUTICS PLC | 31 | Q3 2023 | 9.3% |
| TREVENA INC | 31 | Q3 2021 | 3.3% |
| AKARI THERAPEUTICS PLC | 31 | Q2 2023 | 0.3% |
| ARDELYX INC | 29 | Q3 2021 | 11.9% |
| RIGEL PHARMACEUTICALS INC | 29 | Q2 2020 | 0.6% |
| EPIZYME INC | 28 | Q1 2020 | 9.6% |
View NEA Management Company, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
View NEA Management Company, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.